We help organisations – who may be at any stage of developing a new diagnostic technology – by providing access to an extensive range of clinical samples and robust NHS lab performance testing.
This provides evidence to support the independent diagnostic test evaluation necessary to move new innovative technologies to the next stage of their development or to launch for mainstream use.
Based in the Biosphere, Newcastle Helix life sciences quarter, the lab team works with UK and international clients around the globe to accelerate the advancement and use of the most innovative diagnostics.
Our diagnostic evaluation and validation services use cutting-edge technology to provide evidence to support the independent evaluation and validation necessary to move new technologies to the next stage of their development or to launch to market for mainstream use.
Our combined HTA-registered Newcastle Hospitals Biobank in partnership with Novopath gives access to a range of over three million prospectively collected and archived tissue and liquid samples for our clients.
Offering a range of specialist expertise, our team includes molecular biologists, life scientists, methodologists and clinical research nurses.
We are proud to have already supported the development of diagnostic devices to provide rapid identification of health threats including infectious diseases and cancers.
Watch our video showing our journey since our creation and read our case studies. If you think we could help with your work, we’d be delighted to hear from you. Please visit the contact us page to get in touch.
